Last updated on November 2016

SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies an Open Label Pilot Study


Brief description of study

The primary objective of the study is to assess the effect of MD1003 on motor and sensory conduction, in patients suffering from demyelinating polyneuropathies.

Clinical Study Identifier: NCT02967679

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Alain CREANGE, MD

H pital Henri Mondor, Cr teil, France
Creteil, France
  Connect »